Showing results (71-80 of 121) with videos related to
Sort By:
Pageof 13
Kidney360|January 26, 2023
A Meta-Analysis and Cohort Study of Histopathologic and Clinical Outcomes in ANCA-Negative versus -Positive VasculitisLauren Floyd, Adam D Morris, Mohamed E Elsayed, et al.Seminars in Arthritis and Rheumatism|January 7, 2014
Clinical characteristics and outcome of pauci-immune glomerulonephritis in African AmericansDuvuru Geetha, Caroline J Poulton, Yichun Hu, et al.Journal of Nephrology|September 5, 2014
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximabDuvuru Geetha, Cees Kallenberg, John H Stone, et al.Clinical Rheumatology|May 25, 2019
Correction to: Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomesVeena S Katikineni, Sam Kant, Eric J Gapud, et al.Lupus|April 16, 2026
Association between interstitial fibrosis/tubular atrophy (IFTA) on kidney biopsies and anti Ro60 antibody positivity in patients with lupus nephritis (LN)Homa Timlin, Abbal Koiral, Avi Rosenber, et al.Clinical Journal of the American Society of Nephrology : CJASN|May 26, 2012
Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipientsAdnan Sharif, Nada Alachkar, Serena Bagnasco, et al.Cureus|September 10, 2019
Clinical Characteristics of Hydralazine-induced LupusHoma Timlin, Michael Wu, Monica Crespo-Bosque, et al.Clinical Rheumatology|May 1, 2019
Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomesVeena S Katikineni, Sam Kant, Eric J Gapud, et al.Kidney International Reports|September 11, 2018
Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody-Associated VasculitisDuvuru Geetha, Qiuyu Jin, Jennifer Scott, et al.RMD Open|October 6, 2025
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamideDuvuru Geetha, Thomas Neumann, Alexandre Karras, et al.Pageof 13